KRT20 and neoplasm: Furthermore, the authors highlighted the organisation of CD20+ B cells in the immune component of the tumour and identified B cell clusters in 75% of tumours from the NMIBC Ta low-grade group, and in 81% of tumours from the MIBC group [76].